...
首页> 外文期刊>Virchows Archiv >Tubulocystic carcinoma of the kidney: a histologic, immunohistochemical, and ultrastructural study
【24h】

Tubulocystic carcinoma of the kidney: a histologic, immunohistochemical, and ultrastructural study

机译:肾小管膀胱癌:组织学,免疫组化和超微结构研究

获取原文
获取原文并翻译 | 示例
           

摘要

Tubulocystic carcinoma of the kidney (TCCK) is a tumor entity, which is not yet included in the WHO classification of renal tumors. The histogenesis of this neoplasm is uncertain. This study was undertaken to determine (1) the incidence of TCCK and (2) immunohistochemical and ultrastructural characteristics of those tumors that qualify as TCCK by the current definitions. From January 1, 2003 to December 31, 2012, a total of 615 renal cell carcinomas (RCCs) were seen by the Department of Pathology, University of Maryland Medical Center. Four TCCKs were identified (4/615, <1 %). TCCK is a distinctive group of kidney tumors with a male predominance and noteworthy macroscopic spongy appearance. Microscopically, the tumors were composed of tubules and cysts lined by a single layer of eosinophilic, columnar, cuboidal, flat, or hobnail cells with large nuclei and prominent nucleoli separated by a thin fibrotic stroma. In all TCCKs, the majority of neoplastic cells showed immunohistochemical (CD10+, RCC+, vimentin+, and AMACR+) and ultrastructural (abundant long brush border microvilli) characteristics of proximal renal tubules. In few cells, the microvilli were shorter and sparse with cytoplasmic interdigitation analogous to intercalated cells of the collecting ducts. Focal positivity for BerEP4 (a marker preferentially expressed in distal renal tubules) was also noted. The major differential diagnostic considerations are oncocytoma, multilocular cystic renal cell carcinoma, and cystic nephroma/mixed epithelial and stromal tumor of the kidney. TCCK seems to have a favorable prognosis. In the current series, none of the patients had local recurrence or metastatic disease.
机译:肾小管囊癌(TCCK)是一种肿瘤实体,尚未包括在WHO肾肿瘤分类中。这种肿瘤的组织发生是不确定的。进行这项研究是为了确定(1)TCCK的发生率,以及(2)根据当前定义符合TCCK的那些肿瘤的免疫组织化学和超微结构特征。从2003年1月1日至2012年12月31日,马里兰大学医学中心病理科共观察到615个肾细胞癌(RCC)。确定了四个TCCK(4/615,<1%)。 TCCK是肾脏肿瘤的独特组,男性占主导地位,宏观海绵状外观值得注意。在显微镜下,肿瘤由小管和囊肿组成,内衬单层嗜酸性,柱状,长方体,扁平或钉书状细胞,细胞核较大,核仁突出,并由薄的纤维化基质隔开。在所有TCCKs中,大多数肿瘤细胞表现出近端肾小管的免疫组织化学(CD10 +,RCC +,波形蛋白+和AMACR +)和超微结构(长刷缘微绒毛丰富)特征。在少数细胞中,微绒毛更短且稀疏,胞质指状细胞类似于收集管的插层细胞。还注意到了BerEP4(在远端肾小管中优先表达的标志物)的局部阳性。主要的鉴别诊断考虑因素是肿瘤细胞瘤,多眼性囊性肾细胞癌和肾的囊性肾癌/上皮和基质混合瘤。 TCCK预后良好。在当前系列中,没有患者有局部复发或转移性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号